JPX : 3183.T

WIN-Partners Co., Ltd.

$1303 JPY

-$18 (-1.36%)

Volume
17.7K
Average Volume
16.12K
Market Capitalization
$35.83B
P/E Ratio
17.14
Dividend Yield
4.14%
Price Target
Year High
$1527.00
Year Low
$1175.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.70
Company Overview

JPX

Hideumi Akizawa

Medical - Distribution

Healthcare

3183.T

653

JP

JPY

https://www.win-partners.co.jp

81 3 3548 0790

N/A

N/A

Liquidity Metrics

0.03

1.70

1.54

0.63

0.00

Sales & Valuation

$90.39B

0.40

1.55

0.00

0.00

Profitability

$75.98

$2.12B

2.34%

3.41%

9.32%

4.18%

P/E Metrics

17.14

2.17

2.17

Analyst Price Target & Rating

Buy

4/5

0 Analysts

%

Financial Health Scores

3.82

4/9

$17.62B

$50.63B

$27.34B

$3.05B

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Hideumi Akizawa President, Chief Executive Officer & Chairman
Keiji Matsumoto Director, Executive Officer and GM of Administration Headquarters, General Affairs & System Dev.
Hiromi Mitagami Director, Operating Officer & GM of Sales Management Department
Yuji Akita Executive Officer & Director
Poll Results

No votes yet today — be the first to share your view!

About WIN-Partners Co., Ltd. (JPX:3183.T) Stock

Established in 1973 and headquartered in Tokyo, Japan, WIN-Partners Co., Ltd. leverages its subsidiaries to distribute a comprehensive range of medical devices to healthcare institutions, primarily across Japan. Its diverse product offerings include cutting-edge cardiovascular tools such as percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters. The company also supplies devices for cardiac rhythm management, like pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters. Furthermore, WIN-Partners provides structural and peripheral vascular products, including stent grafts, transcatheter heart valves, mechanical heart valves, and various stents and embo ... lic coils. Rounding out its portfolio are diabetes management systems such as insulin pumps and continuous glucose monitoring devices, in addition to magnetic resonance imaging equipment.

Frequently Asked Questions

What is the current WIN-Partners Co., Ltd. (3183.T) stock price?

WIN-Partners Co., Ltd.(JPX:3183.T) stock price is $1303 in the last trading session. During the trading session, 3183.T stock reached the peak price of $1527 while $1175 was the lowest point it dropped to. The percentage change in 3183.T stock occurred in the recent session was --1.36% while the dollar amount for the price change in 3183.T stock was -$18.

3183.T's industry and sector of operation?

The JPX listed 3183.T is part of Medical - Distribution industry that operates in the broader Healthcare sector.

Who are the executives of 3183.T?

Hideumi Akizawa | President, Chief Executive Officer & Chairman
Keiji Matsumoto | Director, Executive Officer and GM of Administration Headquarters, General Affairs & System Dev.
Hiromi Mitagami | Director, Operating Officer & GM of Sales Management Department
Yuji Akita | Executive Officer & Director
|

How many employees does 3183.T have?

Number of 3183.T employees currently stands at 653. 3183.T operates from Kyobashi Edogrand, Tokyo, TY 104-0031, JP.

Link for 3183.T official website?

Official Website of 3183.T is: https://www.win-partners.co.jp

How do I contact 3183.T?

3183.T could be contacted at phone #81 3 3548 0790 and can also be accessed through its website. 3183.T operates from Kyobashi Edogrand, Tokyo, TY 104-0031, JP.

How many shares of 3183.T are traded daily?

The average number of 3183.T shares traded daily for last 3 months was 16.12K.

What is the market cap of 3183.T currently?

The market value of 3183.T currently stands at $35.83B with its latest stock price at $1303